Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the relative potency for bronchoprotective effect of
formoterol Novolizer 12 µg (test) compared to formoterol Aerolizer 12 µg (reference).
Phase:
Phase 2
Details
Lead Sponsor:
MEDA Pharma GmbH & Co. KG
Collaborators:
ClinResearch, GmbH NuCara Pharmacy, Waterloo, USA Prof. Hochhaus, Gainesville, USA Trio Clinical Research, LLC, Raleigh, USA